134 related articles for article (PubMed ID: 31029232)
1. Breast Ductal Carcinoma in Situ: Precursor to Invasive Breast Cancer.
Coleman WB
Am J Pathol; 2019 May; 189(5):942-945. PubMed ID: 31029232
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ: progression to invasive cancer is slow and only occurs in a minority of case.
Prescrire Int; 2013 Dec; 22(144):301. PubMed ID: 24600735
[TBL] [Abstract][Full Text] [Related]
3. [Establishing a cytogenetic and morphological progression models of invasive breast cancer. Comparative genomic hybridization (CGH) in malignant and premalignant tumors of the female breast].
Bürger H; Poremba C; Diallo R; Dockhorn-Dworniczak B; Böcker W
Pathologe; 2000 Sep; 21(5):375-82. PubMed ID: 11092010
[TBL] [Abstract][Full Text] [Related]
4. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Latta EK; Tjan S; Parkes RK; O'Malley FP
Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
[TBL] [Abstract][Full Text] [Related]
5. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
6. Part III. The pathobiology of ductal carcinoma in situ.
Catzavelos C
Curr Probl Cancer; 2000; 24(3):125-40. PubMed ID: 10919315
[No Abstract] [Full Text] [Related]
7. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ associated with triple negative invasive breast cancer: evidence for a precursor-product relationship.
Thike AA; Iqbal J; Cheok PY; Tse GM; Tan PH
J Clin Pathol; 2013 Aug; 66(8):665-70. PubMed ID: 23539741
[TBL] [Abstract][Full Text] [Related]
9. [Node status in 454 ductal breast cancers cases according to the association with in situ component].
Carabias-Meseguer P; Cusidó-Gimferrer M; Zapardiel-Gutiérrez I; Tresserra-Casas F; Fábregas-Xauradó R; Xercavins-Montoya J
Ginecol Obstet Mex; 2011 Jan; 79(1):5-10. PubMed ID: 21966777
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA.
Volinia S; Galasso M; Sana ME; Wise TF; Palatini J; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3024-9. PubMed ID: 22315424
[TBL] [Abstract][Full Text] [Related]
11. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
12. The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin.
Schnitt SJ
Breast Cancer Res; 2009; 11(1):101. PubMed ID: 19291276
[TBL] [Abstract][Full Text] [Related]
13. [Cytodiagnosis of invasive ductal breast cancer].
Finsterer H
Verh Dtsch Ges Pathol; 1985; 69():502-7. PubMed ID: 3006391
[No Abstract] [Full Text] [Related]
14. Biology of ductal carcinoma in situ classification based on biologic potential.
Tsikitis VL; Chung MA
Am J Clin Oncol; 2006 Jun; 29(3):305-10. PubMed ID: 16755185
[TBL] [Abstract][Full Text] [Related]
15. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
16. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
Wärnberg F; Nordgren H; Bergkvist L; Holmberg L
Br J Cancer; 2001 Sep; 85(6):869-74. PubMed ID: 11556839
[TBL] [Abstract][Full Text] [Related]
17. Ductal carcinoma in situ.
Swain SM
Cancer Invest; 1992; 10(5):443-54. PubMed ID: 1327429
[No Abstract] [Full Text] [Related]
18. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
19. The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern.
Hardman PD; Worth A; Lee U; Baird RM
Can J Surg; 1989 Jan; 32(1):56-60. PubMed ID: 2535949
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive breast carcinoma.
Posner MC; Wolmark N
Breast Cancer Res Treat; 1992; 21(3):155-64. PubMed ID: 1325215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
